The Faculty of Medical Sciences of the University of Groningen is the second oldest medical faculty in The Netherlands and was established in 1614. The University Medical Center Groningen (UMCG) was established in 2005 as a joint activity of the University of Groningen and the Academic Hospital Groningen (AZG) and is one of the largest hospitals in the Netherlands. It is also the largest employer in Northern Netherlands with over 10,000 employees. Its major tasks involve medical scientific education and carrying out medical scientific research. Characteristic for the research at the UMCG is the combination of fundamental research and patient-oriented (clinical) research. The UMCG provides a highly stimulating internationally orientated research environment, in which scientists from various pre-clinical disciplines (medical biologists, pharmacists, chemists, and physicists) closely collaborate with clinical academic staff from a range of specialties. The UMCG will participate in I-DireCT with all its appropriate expertise, laboratories and facilities.
The University Hospital Wuerzburg (UKW) is a major academic teaching hospital located in the north of Bavaria, Germany. It strives for excellence in patient-care, which is achieved through dedicated teaching and education of physicians and scien-tists as well as world-class basic and transla-tional research. Seeking excellence in the training of young researchers and ensuring equal access and opportunities are of paramount importance for the Hospital. UKW has more than 6,100 permanent staff, of which 924 are physicians and over 100 are biologists and pharma-cists involved in both clinical care and aca-demic research. The hospital provides pas-sionate, state-of-the-art care for over 63,000 in-patients and 240,000 day care patients per year. In 2016 alone, UKW has been granted over 120 research and training actions from national and international funding bodies. Currently the Hospital implements 19 EU-funded projects. On average UKW generates revenues of over 35 million € through exter-nal funding per year.
InoCure s.r.o. is a Czech SME focused on development of novel drug delivery systems and nanosystems. InoCure provides a full chain of nanosystem development from design and construction of devices, through chemical optimization to functional testing. Role of InoCure in iDirect project is development of core/shell particles through electrohydrodynamic atomization. The systems production is up-scaled to industrial quantities and properties of particles are characterized by microscopic, spectroscopic and pharmacokinetic methods. For more information: www.inocure.cz
The Berlin based contract research company Surflay Nanotec GmbH focuses on tailored development of surface technologies, nano-coatings, encapsulation of active materials, production of fluorescent polymers and miniaturized sensors (bioanalysis, pH, temperature, oxygen etc.). The key technology of the company is the Layer-by-Layer method, a nano-coating technology which deposits charged polymers or particles at nearly any surface in a layered fashion in order to fine-tune surface properties or encapsulate active materials. More recently Surflay Nanotec has introduced the first commercial bioanalysis platform based on microsensors and Low-Q Whispering Gallery Modes.
KAHR Medical, a privately-held biotechnology company, is based in Israel and is developing a novel drug platform based on bi-functional, immunotherapeutic fusion proteins, targeting multiple cancer indications. KAHR’s proprietary technology, known as DSP (Dual Signaling Proteins), enables the construction of targeted biological drugs with two functional ends, which can simultaneously block and/or activate two reinforcing biological signals resulting in a synergistic outcome.
Founded in 2000, European Research and Project Office GmbH (EURICE) provides comprehensive support services for the planning, initiation, and implementation of international collaborative research and innovation projects. EURICE ranks among Europe’s largest project management offices, with a dedicated team of >40 staff members with different professional and scientific background and expertise, such as law, medicine, biology, chemistry, communications, social and computer sciences. Within Horizon 2020, EURICE has been successfully involved in the coordination of 30 collaborative projects. The portfolio of EURICE ranks from collaborative projects in the field of experimental research (TRL 2-4) up to demonstration and technology validation projects in an operational environment (TRL 5-8). EURICE accompanies researchers and innovative companies through the entire life cycle of a project – from the first idea to successful project completion – and beyond. EURICE has also developed specific training modules (on-site, webinars, audio-visual) for successful innovation and project management in collaborative Horizon 2020 research and innovation projects. We welcomed over 4,000 users (Researchers, SMEs, EC project monitoring staff, Reviewers) in our extensive training programme in 2017 alone.
Learning By Simulation (LBS) strongly believes in the use of simulations to familiarize individuals with complex matter in a short time. In our simulations we apply a unique condensed method of training that allows you to gain insight in the overall working process of your organization. Participants will operate in a team setting to make strategic choices, to be decisive and to improvise. They will learn to speak the language of your colleagues and to respect other disciplines. LBS offers participants the opportunity to experience this very intensive method of learning in order to better understand their professional environment. The past decade, LBS designed and conducted a number of specific simulations for the pharmaceutical industry. More than ten years of experience using the simulation training method within the pharmaceutical industry have convinced us that this is the most effective and efficient training method for employees to gain insight into complex processes. The heart of LBS consists of three highly experienced people in pharmaceutical research & development and simulation course development.